Involvement of the posterior segment of the eye occurs in 14-43% of uveitides in Western societies. representing an annual incidence of 3.9�7.3/100 000. 1 In the majority of these patients inflammatory episodes can be controlled by systemic or periocular steroids and disease remission can be maintained either without drugs or by prescribing a low daily maintenance dose. A proportion of posterior uveitis patients require 20 mg or more of prednisolone per day for long periods in order to prevent relapse and this obviously has major side-effects in the long term. Other patients, such as those with Beh<;et's disease, inexorably lose vision despite relatively good long-term control of their inflammatory disease.2 Drugs which specifically control inflammatory activity within the eye and prevent the development of the sequelae of uveitis without a signifi cant risk of systemic toxicity are clearly lacking.
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The major reasons for loss of vision are macular oedema due to breakdown of the blood�retina barrier ( Fig. 1) , direct inflammatory damage to retinal elements, retinal vessel closure with consequent ischaemic changes, and glaucomatous optic neuropathy. In order to develop new therapies for uveitis, an understanding of the immun ological mechanisms which lead to these sequelae is essential. The main difficulty in achieving this is the rela tive inaccessibility of the tissue involved.
Immunohistochemical studies of the retina and choroid of eyes enucleated for the complications of various types of posterior uveitis such as Beh<;et's disease/ sarcoidosis and sympathetic ophthalmia� have demonstrated that the predominant infiltrating cell is the CD4+ T cell. Although this does not prove that the aetiology is autoimmune, the absence of a demonstrable cause, in combination with the recognised associations with other putative autoimmune conditions and the clinical response to immunosuppres sive drugs, provide strong circumstantial evidence for an autoimmune aetiology.
In other organ-specific putative T-cell-mediated auto- immune diseases such as rheumatoid arthritis5.6 and Graves' thyroiditis,7.8 the functional characteristics of lymphocytes extracted from inflamed tissue have been studied extensively in vitro. The information obtained from such work has contributed to many of the current concepts of how autoimmune diseases develop. If it were feasible to obtain viable lymphocyte prep arations from the retinas of patients with uveitis, we would hope to discover how T cells can cross the blood-retina barrier to induce an inflammatory response within the normally protected environment of the retina. A step in this direction is the characterisation of lymphocytes from the retinas of animals with experimental autoimmune uveoretinitis (EAU).
Functional and phenotypic data have been reported from lymphocytes obtained from the retinas of animals with EAU.9 Expression of activation markers, antigen specific lymphocyte proliferation and cytokine mRNA production within the retina were examined. [() The results are reviewed in the context of our current knowledge of the pathogenesis of human uveitis.
EXPERIMENTAL AUTOIMMUNE UVEORETINITIS
Animal models of posterior uveitis (EA U) can be induced by peripheral injection of a purified retinal antigen (e.g. S antigen, S-Ag) emulsified in adjuvant, which leads to the development of retinochoroiditis after approximately 2 weeks. I I Although uveal antigens have been shown to cause anterior uveitis, they are much less effective in pro ducing uveoretinitis. 1 2. 13 The injection of antigen into the foot pad results in the generation of activated ocular antigen-specific CD4+ T cells in the popliteal and inguinal lymph nodes. They enter the circulation and some reach the retinal vasculature to cause EAU. When removed from one animal, cultured in vitro in the presence of antigen and then injected into a syngeneic animal, these lymphocytes can induce EAU in the recipient (adoptive transfer), demonstrating that the CD4+ T cell is responsible for induction of the disease.14
Induction of EAU
EAU was induced in the Lewis rat model by an injection into the foot pad of 50 flg purified bovine retinal S-Ag emulsified in complete Freund's adjuvant containing 2.5 mg/ml Mycobacterium tuberculosis. At the same time 5 x 109 killed Bordetella pertussis organisms were injected intraperitoneally. With this regime a severe fulminant uveoretinitis, with concomitant anterior uveitis, hypopyon and vitritis, develops between days 11 and 13 after immunisation. The inflammation peaks in severity from days 13 to 15 and gradually resolves by days 18 to 21 (7-10 days after onset).
PHENOTYPE AND ACTIVATION STATE OF CD4+ T LYMPHOCYTES WITHIN THE RETINA
T cell subset phenotypes have previously been studied in retinal infiltrates in EAU using immunohistochemis try. 1 5 . 1 6 These reports were largely qualitative and the expression of lymphocyte activation markers by individ ual subsets was not examined. As there is some evidence that lymphocytes within the eye in EAU are activated, probably reflecting the method of their recruitment from the circulation, we examined T cell subsets in the retina by immunocytochemistry and flow cytometry so that levels of co-expression of the interleukin-2 receptor (IL-2R) and CD45R (an isoform of the leucocyte-common antigen) by the CD4+ subset could be examined. Lymph node and per ipheral blood lymphocytes were compared with those from retina. Significance was assessed using the Wilcoxon rank sum test.
Lymphocyte Subsets in the Retina
Eighty-one per cent of the total lymphocytes infiltrating the retina in early disease were CD4+ (Fig. 2) . When the CD4+ T cells are examined in isolation, IL-2R expression in the retina was significantly higher than in either lymph node or peripheral blood preparations (p<O.OI) (Table I) confirming that at least 34% of these cells are activated. This marker is expressed only transiently and such a high level implies that a large proportion of the CD4+ T cells in the retina have been activated.
There was similarly a sharp contrast between the per centage of CD4+ T lymphocytes expressing CD45R in inflamed retina and those in peripheral blood (p<O.OOI) and lymph nodes (p<O.Ol ). CD45R labels two-thirds of peripheral blood CD4+ T cells in the normal rae7 and iden tifies a subpopulation which produces IL-2 and inter feron-y (IFN-y).18 The C045W subset differs functionally, produces mainly IL-4, -5 and -6, and has been implicated in the suppression of autoimmune diseases induced by CD45R+ CD4+ T cells.
However, the picture is confused somewhat by the CD45R+ subset which ceases to express this marker after activation, and although it is possible that the 95% of CD4+ T cells in the retina which are CD45R-might have originated from the constitutively CD45R-population, it is more likely that they are CD45R-because they have been activated. This result does illustrate that lympho cytes within the retina are phenotypically different from those in the peripheral blood, explaining the lack of speci ficity of many peripheral blood markers in uveitis.
Similar levels of CD45R expression have been observed in studies in human rheumatoid arthritis where the CD45RO+ T lymphocyte (present on activated CD4+ T lymphocytes in the human and analogous in a number of respects to CD45R-in the rat) is the predominant lympho cyte in the inflamed synovial joint. Evidence from the rheumatoid joint suggests that lymphocytes of this pheno type accumulate in the retina due to selective migration or retention rather than local proliferation. 1 9
Late Disease
During disease resolution, the relative proportion of CD8+ T lymphocytes increased in the retina (p<O.05), as pre viously reported.ls,16 It has been suggested that this might be due to selective retention within the retina, 15 the CD8+ T cells having an immunosuppressive role. However, recent studies of CD8-depleted rats with EAU do not support this20 and analysis of other cell phenotypes demonstrates that there is a concurrent increase in B cell levels (p<O.05) and C045R+ CD4+ T cells as well as CD8+ T cells.
It has been shown that the CD45R+ CD4+ popUlation includes some cells which may sub serve memory func tion. 21 Although it is possible that those C045W cells seen in the retina in late disease are memory cells, as suggested by reports of an increased frequency of IFN-y mRAN producing lymphocytes by in situ hybridisation in late disease,22 it is also possible that the destruction of the blood-retina barrier which occurs in EAU results in the passive entry of naive CD45R+ CD4+ T lymphocytes from the circulation. The latter possibility is supported by the relatively mixed lymphocyte population which we have observed in the retina in late disease.
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ANTIGEN SPECIFICITY OF LYMPHOCYTES WITHIN THE RETINA
Evidence from adoptive transfer experiments suggests that uveitis develops when only a small proportion of injected ocular antigen-specific CD4+ T lymphocytes accumulate in the eye.23.24 Congenitally athymic Lewis rats fail to develop disease on adoptive transfer of uveito genic T cell lines alone, but the capacity to induce EAU is restored when these animals are immunologically recon stituted with spleen and thymus cells from syngeneic euthymic donors. It is probable that only a small number of uveitogenic lymphocytes are required to initiate an inflammatory response within the eye and the majority are recruited from elsewhere in the immune system during an amplification phase. 2 5 This being the case we would expect only a small pro portion of lymphocytes within the retina to be specific for the inducing antigen, S-Ag. In order to investigate this, the proliferative response of lymphocytes extracted from ret inas to S-Ag in tissue culture was compared with that to purified protein derivative of M. tuberculosis (PPO), a relevant non-ocular antigen present in the adjuvant used to induce EAU. The stimulation indices (SI) obtained from retinal lymphocyte preparations in response to stimulation with S-Ag and PPD were modest but similar in magnitude and significant (Table II) . The response to S-Ag could be blocked by anti-MHC class II monoclonal antibodies (mAb), indicating that it was CD4+ T-cell-mediated.
The proliferative response observed in lymph node preparations was consistently greater than that in retinal lymphocyte preparations and similarly blocked by anti MHC class II mAb, suggesting a low frequency of cells specific for the antigens tested within the retina. However, previous studies of the interaction of T cell lines with ret inal pigment epithelium (RPE)26 and Muller cell27 cultures have suggested that although retinal cells can stimulate T cell lines in vitro by presenting antigen to them under very carefully controlled circumstances, it seems likely that Muller cells normally have an overall inhibitory influence on lymphocyte proliferation in vivo, possibly explaining the weakness of the proliferative response to antigen which we observed. 28.29 Studies in other autoimmune conditions have suggested that with progression of the disease, diversification of the range of antigen-specificities may occur in inflamed tis sue.30 This would be in keeping with our observations, but further investigation of lymphocyte function in isolation, separated from the influence of other resident retinal cells, is required and this is logistically more difficult. 2.8 ± 0.44 5.1 ± 1.13 (9) 2.8 ± 0.39 3.8 ± 0.64 (4) 1.6 ± 0. 17 1.8 ± 0.50 (6) Mean stimulation index ± SEM (11) for lymphocyte proliferation assays.
CYTOKINE PRODUCTION WITHIN THE INFL AMED RETINA
The CD4+ T lymphocyte is believed to influence the development of the inflammatory response in the retina by a combination of mechanisms which include activation of the retinal capillary endothelium, MHC class II expression on resident retinal cells and direct retinal par enchymal cell damage. The common factor which influ ences all of these is the cytokine milieu created in the retina by the infiltrating lymphocytes. Although CD4+ T lymphocytes have been demonstrated to have a cytotoxic effect in some circumstances,31.32 the majority of their effects appear to be mediated via the production of cyto kines. It is possible, therefore, that selective interference with cytokine production or with cytokine receptors could have a profound effect on the inflammatory response. In 1986 Mosman et al. reported that murine T cell clones in long-term culture displayed two distinct patterns of cytokine production," and so the terms T helper type I (Thl) and T helper type 2 (Th2) were coined. Thl cells produce IL-2, IFN-y and Iymphotoxin (LT) and are believed to be important in delayed-type hypersensitivity reactions. Th2 cells, on the other hand, produce interleu kins-4, -5, -6 and -I 0, (IL-4, IL-5, IL-6 and IL-IO) and their main role is in helping B cells. Although there is some evidence that this division may not be so clearcut in man,34 it provides a useful working model.
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response and uveitogenic T cell lines have been reported to demonstrate a Thl pattern of cytokine secretion (R. R. Caspi, unpublished). However, CD4+ T lymphocytes in retinal infiltrates in EAU have shown a mixed pattern of cytokine mRNA production by in situ hybridisation. 35 As immunisation with S-Ag provokes a humoral as well as a cellular response and activated Th2s involved in gener ation of this humoral response can cross the blood-retina barrier, it would be surprising if retinal infiltrates exhibited only a purely Thl pattern of cytokine secretion. Cytokine mRNA production within the retina in EAU has also been examined using reverse transcription-poly merase chain reaction (RT -PCR) followed by Southern blotting and hybridisation (Fig. 3) . Total RNA was extracted from whole tissue and mRNA present in the sample selectively reverse transcribed to complementary DNA (cDNA). In the polymerase chain reaction, minute quantities of cDNA specific for the lymphokine in ques tion were selectively amplified during repetitive cycles of DNA denaturation and synthesis. �-actin cDNA sequences were also amplified by PCR to ensure that each cDNA sample had been reverse transcribed to a compar able degree.
The PCR products were analysed initially by agarose gel electrophoresis and then transferred onto nylon mem branes (Southern blotting). The Southern blots were probed with a radiolabelled DNA fragment the base pair sequence of which was complementary to part of the IFN-y a.
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a. c. amplified lymphokine sequence (hybridisation) and auto radiographed. This is an extremely sensitive method of detecting PCR products.
In preliminary experiments IFN-y, IL-2 and IL-4 mRNA were detected relatively early in EAU, 24--48 hours from the onset of disease. The signal for IL-4 was consistently weaker in that it was detectable only by hybridisation and autoradiography, in contrast to the IL-2 and IFN-y lymphokine PCR products which were detect able by agarose gel electrophoresis alone (Fig. 3) . These findings would suggest that there are both Thl-like and Th2-like patterns of cytokine mRNA produced in the ret ina in early EAU and that there is, if anything, a predom inance of Thl-like cells. Interestingly, IL-4 mRNA seems to persist with similar intensity into late disease, while IL-2 and IFN-y mRNA products are more difficult to detect in late disease. It may be that this indicates a relative shift towards a Th2 pattern at this stage; however, as IL-4 may be produced by cells other than T lymphocytes, analysis of mRNA production by another Th2 cytokine such as IL-IO will be necessary to confirm that the pres ence of IL-4 mRNA does indicate Th2 activity. Tran scription of lymphokine sequences to mRNA does not necessarily imply translation into protein; however, pre vious immunohistochemical studies which have found IFN-y protein in relative abundance in inflamed retina in EAU3S and the high expression of IL-2R on lymphocytes in the retina described above, would tend to support the conclusion that these mRNA species are translated into protein in the retina during EAU.
CONCL USION
Evidence to date suggests that CD4+ lymphocytes found in the retina in the early stages of established animal models of autoimmune disease are highly activated and different phenotypically from those found in peripheral blood. Although the disease may be initiated by a small number of lymphocytes specific for one antigen, diversification of the range of antigen specificities probably occurs as the response mounts and other lymphocytes are recruited into the retina.
Many of the mechanisms involved in this recruitment and in the subsequent tissue damage within the retina are dependent on the nature of the cytokine environment. IFN-y causes MHC class II molecule expression in aber rant sites. IFN-y in combination with LT, tumour necrosis factor or IL-I is responsible for the appearance of adhe sion molecules such as E-selectin and ICAM-l on vas cular endothelium.36 Interleukins themselves, or acting indirectly by inducing production of other inflammatory products such as prostaglandins and leukotrienes, may be responsible for the loss of integrity of the blood-retina barrier.
It is likely that specific anti-lymphokine therapy to tame the unwanted effects of IFN-y and other cytokines will have a profound effect on the management of intraocular inflammation and the prevention of its sequelae.
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